Technical Analysis for IMRN - Immuron Limited

Grade Last Price % Change Price Change
F 4.9 1.24% 0.06
IMRN closed up 1.24 percent on Friday, May 14, 2021, on 58 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical IMRN trend table...

Date Alert Name Type % Chg
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Expansion Breakdown Bearish Swing Setup 1.24%
Reversal New Lows Setup Bearish Swing Setup 1.24%
Slingshot Bearish Bearish Swing Setup 1.24%
Stochastic Buy Signal Bullish 1.24%
Volume Surge Other 1.24%
Older End-of-Day Signals for IMRN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 21 hours ago
Up 1% about 24 hours ago
Rose Above Lower Bollinger Band 1 day ago
Down 1% 1 day ago
Down 5% 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Immuron Limited Description

Immuron Limited, a microbiome company, focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. It has a technology platform that enables a shorter development therapeutic cycle. The company markets and sells Travelan for the prevention of travellers’ diarrhea. Its lead product candidate IMM-124E is in Phase 2b clinical trials for NASH and ASH. The company also has other preclinical immunotherapy pipeline products targeting immune-related diseases. Immuron Limited has a research and development collaboration agreement with the Walter Reed Army Institute of Research (WRAIR) for the development of a Shigella vaccine; and Naval Medical Research Center for the testing of Travelan in cell lines of campylobacter and enterotoxigenic escherichia coli. The company was founded in 1994 and is based in Blackburn North, Australia.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Diseases Immunotherapy Medical Research Microbiology Diarrhea Related Disease Related Diseases Bacteria Gram Negative Bacteria Immunotherapeutics Campylobacter Hyperimmune Immune Related Diseases Shigella Tropical Diseases Waterborne Diseases

Is IMRN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 28.99
52 Week Low 1.81
Average Volume 21,083
200-Day Moving Average 7.23
50-Day Moving Average 5.75
20-Day Moving Average 5.29
10-Day Moving Average 5.13
Average True Range 0.29
ADX 13.42
+DI 13.51
-DI 21.65
Chandelier Exit (Long, 3 ATRs ) 4.98
Chandelier Exit (Short, 3 ATRs ) 5.51
Upper Bollinger Band 5.77
Lower Bollinger Band 4.81
Percent B (%b) 0.09
BandWidth 18.10
MACD Line -0.25
MACD Signal Line -0.22
MACD Histogram -0.0277
Fundamentals Value
Market Cap 27.79 Million
Num Shares 5.67 Million
EPS -0.68
Price-to-Earnings (P/E) Ratio -7.21
Price-to-Sales 18.04
Price-to-Book 10.35
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.19
Resistance 3 (R3) 5.17 5.06 5.14
Resistance 2 (R2) 5.06 4.99 5.07 5.13
Resistance 1 (R1) 4.98 4.94 5.02 5.00 5.11
Pivot Point 4.87 4.87 4.89 4.88 4.87
Support 1 (S1) 4.79 4.80 4.83 4.80 4.69
Support 2 (S2) 4.68 4.75 4.68 4.67
Support 3 (S3) 4.59 4.68 4.66
Support 4 (S4) 4.61